Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-t

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Sulfur – selenium or tellurium compound

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514824, A61K 3110

Patent

active

049007572

ABSTRACT:
The present invention relates to the use of bis(3,5-di-tertiary-butyl-4-hydroxyphenylthio)methane in treating atherosclerosis and/or hypercholesterolemia in patients suffering therefrom.

REFERENCES:
patent: 3576883 (1971-04-01), Neuworth
patent: 3862332 (1975-01-01), Barnhart et al.
M. S. Brown, J. L. Goldstein, Ann. Rev. Biochem. 52,223-261 (1983).
G. L. Miller, M.D., Ann. Rev. Med. 31,97-108 (1980).
J. G. Patton, et al., Clin. Chem. 29, 1898-1903 (1983).
S. J. T. Mao, et al., Clin. Chem. 29, 1890-1897 (1983).
S. Parthasarathy, et al., J. Clin. Invest. 77, 641-644 (1986).
T. Kita, et al., Proc. Natl. Acad. Sci. U.S.A. 84, 5828-5931 (1987).
T. E. Carew, et al., Proc, Natl. Acad. Sci. U.S.A. 84, 7725-7729 (1987).
Y. Watanabe, Atherosclerosis 36, 261-268 (1980).
Product labeling for Lorelco.RTM., Physician's Desk Reference, 42nd edition, (1988), Medical Economics Co., Inc., Oradell, NJ.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-t does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-t, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hypocholesterolemic and antiatherosclerotic uses of bix(3,5-di-t will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1168504

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.